Biotech · Private company · San Francisco, CA, US
Jacaranda Biosciences, Inc.
Track this companyFree. Adds Jacaranda Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- eiF2B Activators to Treat Noise-Induced Hearing LossFiscal year 2026 · $1.4MNIH RePORTER 5R44DC020069-03 · fetched Nov 12, 2026
- eiF2B Activators to Treat Noise-Induced Hearing LossFiscal year 2025 · $1.6MNIH RePORTER 2R44DC020069-02A1 · fetched Nov 12, 2026
- Development of UPR-Targeted Treatment for Cisplatin-Induced Ototoxicity.Fiscal year 2024 · $304.8KNIH RePORTER 1R43DC021398-01A1 · fetched Nov 12, 2026